Schr?dinger

In case you missed it, we celebrated Pi Day last week with the release of PyMOL 3.1.4. Download the new and improved PyMOL now to receive the limited edition PyMOL app icon, only available for a limited time. Download here: https://hubs.li/Q03c946L0

We've baked up something exciting for Pi Day! PyMOL 3.1.4 includes feature upgrades and improvements, along with a limited edition app icon to celebrate our favorite science holiday. Download PyMOL 3.1.4 now and get the Pi Mole app icon for a limited time only: https://hubs.ly/Q03bT_Jw0

Designing protein degraders requires complex optimization across multiple parameters. Schr?dinger has been working with industry scientists to develop computational workflows that can address diverse challenges, from predicting ternary complexes to optimizing linker properties. Join our webinar on Wednesday, March 26th to learn more about the latest protein degrader modeling tools and a sneak peak of what’s to come. Register here: https://hubs.li/Q03bxNmK0

We're baking something exciting for the world of molecular visualization. Check back on Friday for a cutting-edge treat, dropping on Pi Day.

Schr?dinger is pleased to announce the appointment of Bridget van Kralingen to our Board of Directors. Read the press release here: https://hubs.li/Q03b38M90

Are you attending the NextGen Biomed Conference in London, United Kingdom? Stop by booth 48 to speak with Schr?dinger scientists and join our workshop on March 12, 12:05 PM GMT titled "Accelerating Biologics Design through Computational Modeling and Collaborative Enterprise Informatics.” Explore our solutions for biologics: https://lnkd.in/eYZVCfCR

Register now for Schr?dinger's European User Group Meeting on June 3-5, 2025 in Budapest, Hungary. This in-person event will convene Schr?dinger team members and customers from across Europe. The interactive program includes scientific presentations, workshops, and panel discussions, as well as networking opportunities and evening social events. Learn more and register: https://hubs.li/Q039qdmZ0

Today Schr?dinger announced that we have expanded our research collaboration with Eli Lilly and Company with the addition of another undisclosed target, building on the previously announced collaboration. Learn more about the collaboration and additional company updates in our fourth quarter and full-year 2024 financial results press release: https://hubs.li/Q038tbjF0 Listen to the LIVE webcast at 4:30PM today for an update on our progress: https://hubs.li/Q038tLxN0

Schr?dinger will announce fourth quarter and full-year 2024 financial results today. Join us at 4:30PM ET for an update on our progress. Listen to the LIVE webcast here: https://hubs.li/Q038jgmr0

Computational methods are revolutionizing drug discovery and becoming indispensable tools in the medicinal chemist's arsenal. In this Drug Hunter Flash Talk, Schr?dinger's Aleksey Gerasyuto will discuss the application of physics-based modeling to inform medicinal chemistry decisions across several drug discovery programs within our internal and collaborative portfolio. Join us for the talk on Thursday, February 27th at 11 AM EST to hear examples of how FEP+ has been employed for potency and selectivity modeling, enabling the efficient discovery and optimization of chemical matter. Register here: https://hubs.li/Q0381-vq0